旅行疫苗市场规模- 按成分(单一和组合疫苗)、疾病类型(甲型和乙型肝炎、流感、百白破、黄热病、脑膜炎球菌、伤寒、狂犬病、麻疹和腮腺炎)、应用、全球预测,2023-2032年
市场调查报告书
商品编码
1368717

旅行疫苗市场规模- 按成分(单一和组合疫苗)、疾病类型(甲型和乙型肝炎、流感、百白破、黄热病、脑膜炎球菌、伤寒、狂犬病、麻疹和腮腺炎)、应用、全球预测,2023-2032年

Travel Vaccines Market Size - By Composition (Mono & Combination Vaccines), Disease Type (Hepatitis A & B, Influenza, DPT, Yellow Fever, Meningococcal, Typhoid, Rabies, Measles & Mumps), Application, Global Forecast, 2023-2032

出版日期: | 出版商: Global Market Insights Inc. | 英文 119 Pages | 商品交期: 2-3个工作天内

价格

受麻疹和登革热等几种新传染病的涌入和现有传染病死灰復燃的推动,旅行疫苗市场规模从 2023 年到 2032 年的复合年增长率预计将达到 9.7%。根据疾病管制与预防中心的数据,2021 年麻疹估计导致 128,000 人死亡,其中大部分是儿童。

旨在改进现有旅行疫苗和开发新疫苗的持续研发活动和投资也将有助于产业成长。举例来说,2023年5月,巴伐利亚北欧公司投资2.74亿美元收购Emergent BioSolutions的旅游疫苗组合,以加强其研发和製造能力。人们越来越关注创造更方便的单剂量疫苗以提供更广泛的保护,这也将增加产品的采用。

整个旅行疫苗产业根据成分、疾病类型、应用和地区进行细分。

就成分而言,2023-2032年组合旅行疫苗的需求可能会出现可观的复合年增长率。组合疫苗用于简化疫苗接种过程并提高旅行者的依从性。这些疫苗对于在不同地区有接触多种传染病风险的旅客特别有益,因为它们限制了多次疫苗接种的需要,同时提供了对多种疾病的保护。消费者越来越倾向于减少所需的注射和注射次数,这也将有利于产品的吸收。

就疾病类型而言,预计到2032 年,乙型肝炎细分市场的旅游疫苗市场将实现显着的复合年增长率。随着医疗旅游业的快速增长,医疗机构越来越重视患者和医疗游客对乙型肝炎疫苗的需求。限制感染传播。乙型肝炎盛行率较高(主要在非洲和亚洲),加上与工作相关的旅行率上升,将推动该细分市场的成长。根据世界卫生组织的数据,2022 年将有近 9,100 万非洲人感染B型或C型肝炎。

从地区来看,由于中产阶级人口的快速增长和对国际旅行的偏好不断增加,预计到 2032 年,亚太地区旅行疫苗市场规模将出现可观的复合年增长率。该地区多个政府正在不断审查和更新与旅游疫苗相关的法规,例如入境要求和疫苗接种证明。医疗保健组织对旅游疫苗重要性的日益重视也将有利于区域市场的扩张。

目录

第 1 章:方法与范围

第 2 章:执行摘要

第 3 章:旅行疫苗市场洞察

  • 产业格局
  • 产业影响力
    • 成长动力
      • 增加旅行和旅游业
      • 提高旅行者对疫苗可预防疾病的认识
      • 政府和其他组织为加强旅行安全所采取的倡议
    • 产业陷阱与挑战
      • 旅行疫苗接种费用高
      • 与旅行疫苗相关的副作用
  • 成长潜力分析
  • COVID-19 影响分析
  • 监管环境
  • 波特的分析
  • PESTEL分析

第 4 章:竞争格局

  • 介绍
  • 公司矩阵分析
  • 全球公司市占率分析
  • 竞争定位矩阵
  • 战略仪錶板

第 5 章:旅行疫苗市场:依构成,2018 年 - 2032 年

  • 主要动向:按构成
  • 单一疫苗
  • 联合疫苗

第 6 章:旅游疫苗市场:依疾病类型划分,2018 年 - 2032 年

  • 主要动力向:依疾病类型
  • 甲型肝炎
  • B型肝炎
  • 流感
  • 白喉、百日咳、破伤风 (DPT)
  • 狂犬病
  • 黄热病
  • 伤寒
  • 麻疹和腮腺炎
  • 脑膜炎球菌
  • 其他疾病疫苗

第 7 章:旅游疫苗市场:按应用,2018 - 2032

  • 主要动向:按应用
  • 出境游
  • 国内旅游

第 8 章:旅行疫苗市场:按地区划分,2018 年 - 2032 年

  • 主要动向:按地区
  • 北美洲
    • 我们
    • 加拿大
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 西班牙
    • 义大利
    • 欧洲其他地区
  • 亚太地区
    • 中国
    • 日本
    • 印度
    • 澳洲
    • 亚太地区其他地区
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 拉丁美洲其他地区
  • 中东和非洲
    • 南非
    • 沙乌地阿拉伯
    • 中东和非洲其他地区

第 9 章:公司简介

  • GSK plc
  • Sanofi
  • Janssen Pharmaceuticals Inc.
  • Pfizer Inc.
  • CSL Ltd.
  • Qiagen N.V.
  • AstraZeneca
  • F. Hoffmann-La Roche Ltd
  • Abbott Laboratories
  • Valneva Inc
Product Code: 6573

Travel Vaccines Market size is poised to record 9.7% CAGR from 2023-2032, driven by the influx of several new infectious diseases and the resurgence of existing ones, including measles and dengue. As per the Centers for Disease Control and Prevention, measles killed an estimated 128,000 people, mostly children in 2021.

The ongoing R&D activities and investments aimed at improving the existing travel vaccines and developing new vaccines will also assist the industry growth. To cite an instance, in May 2023, Bavarian Nordic invested $274M to acquire travel vaccine portfolio of Emergent BioSolutions in a bid to strengthen its R&D and manufacturing capabilities. The growing focus on the creation of more convenient, single-dose vaccines to offer broader protection will also add to the product adoption.

The overall travel vaccines industry is segmented based on composition, disease type, application, and region.

In terms of composition, the demand for combination travel vaccines may record appreciable CAGR from 2023-2032. Combination vaccines are used for simplifying the vaccination process and enhance compliance among travelers. These vaccines are especially beneficial for travelers at risk of exposure to several infectious diseases in different regions as they limit the need for multiple vaccinations while rendering protection against multiple diseases. The rising consumer preference for reducing the number of required injections and shots will also prove favorable for the product uptake.

With respect to disease type, the travel vaccines market from the hepatitis B segment is expected to garner significant CAGR through 2032. With the rapid growth in medical tourism, healthcare facilities are highlighting the requirement for hepatitis B vaccines for patients as well as medical tourists to limit the infection transmission. The higher prevalence of hepatitis B, mainly in Africa and Asia along with the rising rate of work-related travel will drive the segment growth. As per the WHO, nearly 91 million Africans were infected with Hepatitis B or C in 2022.

Regionally, APAC travel vaccines market size is projected to record appreciable CAGR through 2032 due to the rapid growth of the middle-class population and the rising preference for international travel. Several governments in the region are constantly reviewing and updating regulations related to travel vaccines, such as entry requirements and vaccination certificates. The surging emphasis laid by healthcare organizations about the importance of travel vaccinations will also prove favorable for the regional market expansion.

Table of Contents

Chapter 1 Methodology & Scope

  • 1.1 Market definition
  • 1.2 Base estimates & calculations
  • 1.3 Forecast calculation
  • 1.4 Covid-19 impact analysis at global level
  • 1.5 Data validation
  • 1.6 Data sources
    • 1.6.1 Secondary
      • 1.6.1.1 Paid sources
      • 1.6.1.2 Public sources
    • 1.6.2 Primary

Chapter 2 Executive Summary

  • 2.1 Travel vaccines industry 360 degree synopsis, 2018 - 2032 (USD Million)
    • 2.1.1 Business trends
    • 2.1.2 Regional trends
    • 2.1.3 Composition trends
    • 2.1.4 Disease type trends
    • 2.1.5 Application trends

Chapter 3 Travel Vaccines Market Insights

  • 3.1 Industry landscape, 2018 - 2032 (USD Million)
  • 3.2 Industry impact forces
    • 3.2.1 Growth drivers
      • 3.2.1.1 Increasing travel & tourism
      • 3.2.1.2 Increasing awareness about vaccine-preventable diseases among travelers
      • 3.2.1.3 Initiatives by governments and other organizations to enhance travel safety
    • 3.2.2 Industry pitfalls & challenges
      • 3.2.2.1 High cost of travel vaccinations
      • 3.2.2.2 Side effects associated with travel vaccines
  • 3.3 Growth potential analysis
    • 3.3.1 By composition
    • 3.3.2 By disease type
    • 3.3.3 By application
  • 3.4 COVID-19 impact analysis
  • 3.5 Regulatory landscape
  • 3.6 Porter's analysis
  • 3.7 PESTEL analysis

Chapter 4 Competitive Landscape, 2022

  • 4.1 Introduction
  • 4.2 Company matrix analysis, 2022
  • 4.3 Global company market share analysis, 2022
  • 4.4 Competitive positioning matrix, 2022
  • 4.5 Strategic dashboard, 2022

Chapter 5 Travel Vaccines Market, By Composition, 2018 - 2032 (USD Million)

  • 5.1 Key trends, by composition
  • 5.2 Mono vaccines
  • 5.3 Combination vaccines

Chapter 6 Travel Vaccines Market, By Disease Type, 2018 - 2032 (USD Million)

  • 6.1 Key trends, by disease type
  • 6.2 Hepatitis A
  • 6.3 Hepatitis B
  • 6.4 Influenza
  • 6.5 Diphtheria pertussis tetanus (DPT)
  • 6.6 Rabies
  • 6.7 Yellow fever
  • 6.8 Typhoid
  • 6.9 Measles and mumps
  • 6.10 Meningococcal
  • 6.11 Other disease vaccines

Chapter 7 Travel Vaccines Market, By Application, 2018 - 2032 (USD Million)

  • 7.1 Key trends, by application
  • 7.2 Outbound travel
  • 7.3 Domestic travel

Chapter 8 Travel Vaccines Market, By Region, 2018 - 2032 (USD Million)

  • 8.1 Key trends, by region
  • 8.2 North America
    • 8.2.1 U.S.
    • 8.2.2 Canada
  • 8.3 Europe
    • 8.3.1 Germany
    • 8.3.2 UK
    • 8.3.3 France
    • 8.3.4 Spain
    • 8.3.5 Italy
    • 8.3.6 Rest of Europe
  • 8.4 Asia Pacific
    • 8.4.1 China
    • 8.4.2 Japan
    • 8.4.3 India
    • 8.4.4 Australia
    • 8.4.5 Rest of Asia Pacific
  • 8.5 Latin America
    • 8.5.1 Brazil
    • 8.5.2 Mexico
    • 8.5.3 Rest of Latin America
  • 8.6 Middle East & Africa
    • 8.6.1 South Africa
    • 8.6.2 Saudi Arabia
    • 8.6.3 Rest of Middle East & Africa

Chapter 9 Company Profiles

  • 9.1 GSK plc
  • 9.2 Sanofi
  • 9.3 Janssen Pharmaceuticals Inc.
  • 9.4 Pfizer Inc.
  • 9.5 CSL Ltd.
  • 9.6 Qiagen N.V.
  • 9.7 AstraZeneca
  • 9.8 F. Hoffmann-La Roche Ltd
  • 9.9 Abbott Laboratories
  • 9.10 Valneva Inc

Data Tables

  • TABLE 1 Product mapping
  • TABLE 2 Market revenue, by composition (2022)
  • TABLE 3 Market revenue, by disease type (2022)
  • TABLE 4 Market revenue, by application (2022)
  • TABLE 5 Market share, by region (2022)
  • TABLE 6 Global travel vaccines market size, by region, 2018 - 2022 (USD Million)
  • TABLE 7 Global travel vaccines market size, by region, 2023 - 2032 (USD Million)
  • TABLE 8 Global travel vaccines market size, by composition, 2018 - 2022 (USD Million)
  • TABLE 9 Global travel vaccines market size, by composition, 2023 - 2032 (USD Million)
  • TABLE 10 Global travel vaccines market size, by disease type, 2018 - 2022 (USD Million)
  • TABLE 11 Global travel vaccines market size, by disease type, 2023 - 2032 (USD Million)
  • TABLE 12 Global travel vaccines market size, by application, 2018 - 2022 (USD Million)
  • TABLE 13 Global travel vaccines market size, by application, 2023 - 2032 (USD Million)
  • TABLE 14 Industry impact forces
  • TABLE 15 Mono vaccines market size, by region, 2018 - 2022 (USD Million)
  • TABLE 16 Mono vaccines market size, by region, 2023 - 2032 (USD Million)
  • TABLE 17 Combination vaccines market size, by region, 2018 - 2022 (USD Million)
  • TABLE 18 Combination vaccines market size, by region, 2023 - 2032 (USD Million)
  • TABLE 19 Hepatitis A market size, by region, 2018 - 2022 (USD Million)
  • TABLE 20 Hepatitis A market size, by region, 2023 - 2032 (USD Million)
  • TABLE 21 Hepatitis B market size, by region, 2018 - 2022 (USD Million)
  • TABLE 22 Hepatitis B market size, by region, 2023 - 2032 (USD Million)
  • TABLE 23 Influenza market size, by region, 2018 - 2022 (USD Million)
  • TABLE 24 Influenza market size, by region, 2023 - 2032 (USD Million)
  • TABLE 25 Diphtheria pertussis tetanus (DPT) market size, by region, 2018 - 2022 (USD Million)
  • TABLE 26 Diphtheria pertussis tetanus (DPT) market size, by region, 2023 - 2032 (USD Million)
  • TABLE 27 Rabies market size, by region, 2018 - 2022 (USD Million)
  • TABLE 28 Rabies market size, by region, 2023 - 2032 (USD Million)
  • TABLE 29 Yellow fever market size, by region, 2018 - 2022 (USD Million)
  • TABLE 30 Yellow fever market size, by region, 2023 - 2032 (USD Million)
  • TABLE 31 Typhoid market size, by region, 2018 - 2022 (USD Million)
  • TABLE 32 Typhoid market size, by region, 2023 - 2032 (USD Million)
  • TABLE 33 Measles and mumps market size, by region, 2018 - 2022 (USD Million)
  • TABLE 34 Measles and mumps market size, by region, 2023 - 2032 (USD Million)
  • TABLE 35 Meningococcal market size, by region, 2018 - 2022 (USD Million)
  • TABLE 36 Meningococcal market size, by region, 2023 - 2032 (USD Million)
  • TABLE 37 Other disease vaccines market size, by region, 2018 - 2022 (USD Million)
  • TABLE 38 Other disease vaccines market size, by region, 2023 - 2032 (USD Million)
  • TABLE 39 Outbound travel vaccines market size, by region, 2018 - 2022 (USD Million)
  • TABLE 40 Outbound travel vaccines market size, by region, 2023 - 2032 (USD Million)
  • TABLE 41 Domestic travel vaccines market size, by region, 2018 - 2022 (USD Million)
  • TABLE 42 Domestic travel vaccines market size, by region, 2023 - 2032 (USD Million)
  • TABLE 43 North America travel vaccines market size, by country, 2018 - 2022 (USD Million)
  • TABLE 44 North America travel vaccines market size, by country, 2023 - 2032 (USD Million)
  • TABLE 45 North America travel vaccines market size, by composition, 2018 - 2022 (USD Million)
  • TABLE 46 North America travel vaccines market size, by composition, 2023 - 2032 (USD Million)
  • TABLE 47 North America travel vaccines market size, by disease type, 2018 - 2022 (USD Million)
  • TABLE 48 North America travel vaccines market size, by disease type, 2023 - 2032 (USD Million)
  • TABLE 49 North America travel vaccines market size, by application, 2018 - 2022 (USD Million)
  • TABLE 50 North America travel vaccines market size, by application, 2023 - 2032 (USD Million)
  • TABLE 51 U.S. travel vaccines market size, by composition, 2018 - 2022 (USD Million)
  • TABLE 52 U.S. travel vaccines market size, by composition, 2023 - 2032 (USD Million)
  • TABLE 53 U.S. travel vaccines market size, by disease type, 2018 - 2022 (USD Million)
  • TABLE 54 U.S. travel vaccines market size, by disease type, 2023 - 2032 (USD Million)
  • TABLE 55 U.S. travel vaccines market size, by application, 2018 - 2022 (USD Million)
  • TABLE 56 U.S. travel vaccines market size, by application, 2023 - 2032 (USD Million)
  • TABLE 57 Canada travel vaccines market size, by composition, 2018 - 2022 (USD Million)
  • TABLE 58 Canada travel vaccines market size, by composition, 2023 - 2032 (USD Million)
  • TABLE 59 Canada travel vaccines market size, by disease type, 2018 - 2022 (USD Million)
  • TABLE 60 Canada travel vaccines market size, by disease type, 2023 - 2032 (USD Million)
  • TABLE 61 Canada travel vaccines market size, by application, 2018 - 2022 (USD Million)
  • TABLE 62 Canada travel vaccines market size, by application, 2023 - 2032 (USD Million)
  • TABLE 63 Europe travel vaccines market size, by country, 2018 - 2022 (USD Million)
  • TABLE 64 Europe travel vaccines market size, by country, 2023 - 2032 (USD Million)
  • TABLE 65 Europe travel vaccines market size, by composition, 2018 - 2022 (USD Million)
  • TABLE 66 Europe travel vaccines market size, by composition, 2023 - 2032 (USD Million)
  • TABLE 67 Europe travel vaccines market size, by disease type, 2018 - 2022 (USD Million)
  • TABLE 68 Europe travel vaccines market size, by disease type, 2023 - 2032 (USD Million)
  • TABLE 69 Europe travel vaccines market size, by application, 2018 - 2022 (USD Million)
  • TABLE 70 Europe travel vaccines market size, by application, 2023 - 2032 (USD Million)
  • TABLE 71 Germany travel vaccines market size, by composition, 2018 - 2022 (USD Million)
  • TABLE 72 Germany travel vaccines market size, by composition, 2023 - 2032 (USD Million)
  • TABLE 73 Germany travel vaccines market size, by disease type, 2018 - 2022 (USD Million)
  • TABLE 74 Germany travel vaccines market size, by disease type, 2023 - 2032 (USD Million)
  • TABLE 75 Germany travel vaccines market size, by application, 2018 - 2022 (USD Million)
  • TABLE 76 Germany travel vaccines market size, by application, 2023 - 2032 (USD Million)
  • TABLE 77 UK travel vaccines market size, by composition, 2018 - 2022 (USD Million)
  • TABLE 78 UK travel vaccines market size, by composition, 2023 - 2032 (USD Million)
  • TABLE 79 UK travel vaccines market size, by disease type, 2018 - 2022 (USD Million)
  • TABLE 80 UK travel vaccines market size, by disease type, 2023 - 2032 (USD Million)
  • TABLE 81 UK travel vaccines market size, by application, 2018 - 2022 (USD Million)
  • TABLE 82 UK travel vaccines market size, by application, 2023 - 2032 (USD Million)
  • TABLE 83 France travel vaccines market size, by composition, 2018 - 2022 (USD Million)
  • TABLE 84 France travel vaccines market size, by composition, 2023 - 2032 (USD Million)
  • TABLE 85 France travel vaccines market size, by disease type, 2018 - 2022 (USD Million)
  • TABLE 86 France travel vaccines market size, by disease type, 2023 - 2032 (USD Million)
  • TABLE 87 France travel vaccines market size, by application, 2018 - 2022 (USD Million)
  • TABLE 88 France travel vaccines market size, by application, 2023 - 2032 (USD Million)
  • TABLE 89 Spain travel vaccines market size, by composition, 2018 - 2022 (USD Million)
  • TABLE 90 Spain travel vaccines market size, by composition, 2023 - 2032 (USD Million)
  • TABLE 91 Spain travel vaccines market size, by disease type, 2018 - 2022 (USD Million)
  • TABLE 92 Spain travel vaccines market size, by disease type, 2023 - 2032 (USD Million)
  • TABLE 93 Spain travel vaccines market size, by application, 2018 - 2022 (USD Million)
  • TABLE 94 Spain travel vaccines market size, by application, 2023 - 2032 (USD Million)
  • TABLE 95 Italy travel vaccines market size, by composition, 2018 - 2022 (USD Million)
  • TABLE 96 Italy travel vaccines market size, by composition, 2023 - 2032 (USD Million)
  • TABLE 97 Italy travel vaccines market size, by disease type, 2018 - 2022 (USD Million)
  • TABLE 98 Italy travel vaccines market size, by disease type, 2023 - 2032 (USD Million)
  • TABLE 99 Italy travel vaccines market size, by application, 2018 - 2022 (USD Million)
  • TABLE 100 Italy travel vaccines market size, by application, 2023 - 2032 (USD Million)
  • TABLE 101 Rest of Europe travel vaccines market size, by composition, 2018 - 2022 (USD Million)
  • TABLE 102 Rest of Europe travel vaccines market size, by composition, 2023 - 2032 (USD Million)
  • TABLE 103 Rest of Europe travel vaccines market size, by disease type, 2018 - 2022 (USD Million)
  • TABLE 104 Rest of Europe travel vaccines market size, by disease type, 2023 - 2032 (USD Million)
  • TABLE 105 Rest of Europe travel vaccines market size, by application, 2018 - 2022 (USD Million)
  • TABLE 106 Rest of Europe travel vaccines market size, by application, 2023 - 2032 (USD Million)
  • TABLE 107 Asia Pacific travel vaccines market size, by country, 2018 - 2022 (USD Million)
  • TABLE 108 Asia Pacific travel vaccines market size, by country, 2023 - 2032 (USD Million)
  • TABLE 109 Asia Pacific travel vaccines market size, by composition, 2018 - 2022 (USD Million)
  • TABLE 110 Asia Pacific travel vaccines market size, by composition, 2023 - 2032 (USD Million)
  • TABLE 111 Asia Pacific travel vaccines market size, by disease type, 2018 - 2022 (USD Million)
  • TABLE 112 Asia Pacific travel vaccines market size, by disease type, 2023 - 2032 (USD Million)
  • TABLE 113 Asia Pacific travel vaccines market size, by application, 2018 - 2022 (USD Million)
  • TABLE 114 Asia Pacific travel vaccines market size, by application, 2023 - 2032 (USD Million)
  • TABLE 115 China travel vaccines market size, by composition, 2018 - 2022 (USD Million)
  • TABLE 116 China travel vaccines market size, by composition, 2023 - 2032 (USD Million)
  • TABLE 117 China travel vaccines market size, by disease type, 2018 - 2022 (USD Million)
  • TABLE 118 China travel vaccines market size, by disease type, 2023 - 2032 (USD Million)
  • TABLE 119 China travel vaccines market size, by application, 2018 - 2022 (USD Million)
  • TABLE 120 China travel vaccines market size, by application, 2023 - 2032 (USD Million)
  • TABLE 121 Japan travel vaccines market size, by composition, 2018 - 2022 (USD Million)
  • TABLE 122 Japan travel vaccines market size, by composition, 2023 - 2032 (USD Million)
  • TABLE 123 Japan travel vaccines market size, by disease type, 2018 - 2022 (USD Million)
  • TABLE 124 Japan travel vaccines market size, by disease type, 2023 - 2032 (USD Million)
  • TABLE 125 Japan travel vaccines market size, by application, 2018 - 2022 (USD Million)
  • TABLE 126 Japan travel vaccines market size, by application, 2023 - 2032 (USD Million)
  • TABLE 127 India travel vaccines market size, by composition, 2018 - 2022 (USD Million)
  • TABLE 128 India travel vaccines market size, by composition, 2023 - 2032 (USD Million)
  • TABLE 129 India travel vaccines market size, by disease type, 2018 - 2022 (USD Million)
  • TABLE 130 India travel vaccines market size, by disease type, 2023 - 2032 (USD Million)
  • TABLE 131 India travel vaccines market size, by application, 2018 - 2022 (USD Million)
  • TABLE 132 India travel vaccines market size, by application, 2023 - 2032 (USD Million)
  • TABLE 133 Australia travel vaccines market size, by composition, 2018 - 2022 (USD Million)
  • TABLE 134 Australia travel vaccines market size, by composition, 2023 - 2032 (USD Million)
  • TABLE 135 Australia travel vaccines market size, by disease type, 2018 - 2022 (USD Million)
  • TABLE 136 Australia travel vaccines market size, by disease type, 2023 - 2032 (USD Million)
  • TABLE 137 Australia travel vaccines market size, by application, 2018 - 2022 (USD Million)
  • TABLE 138 Australia travel vaccines market size, by application, 2023 - 2032 (USD Million)
  • TABLE 139 Rest of Asia Pacific travel vaccines market size, by composition, 2018 - 2022 (USD Million)
  • TABLE 140 Rest of Asia Pacific travel vaccines market size, by composition, 2023 - 2032 (USD Million)
  • TABLE 141 Rest of Asia Pacific travel vaccines market size, by disease type, 2018 - 2022 (USD Million)
  • TABLE 142 Rest of Asia Pacific travel vaccines market size, by disease type, 2023 - 2032 (USD Million)
  • TABLE 143 Rest of Asia Pacific travel vaccines market size, by application, 2018 - 2022 (USD Million)
  • TABLE 144 Rest of Asia Pacific travel vaccines market size, by application, 2023 - 2032 (USD Million)
  • TABLE 145 Latin America travel vaccines market size, by country, 2018 - 2022 (USD Million)
  • TABLE 146 Latin America travel vaccines market size, by country, 2023 - 2032 (USD Million)
  • TABLE 147 Latin America travel vaccines market size, by composition, 2018 - 2022 (USD Million)
  • TABLE 148 Latin America travel vaccines market size, by composition, 2023 - 2032 (USD Million)
  • TABLE 149 Latin America travel vaccines market size, by disease type, 2018 - 2022 (USD Million)
  • TABLE 150 Latin America travel vaccines market size, by disease type, 2023 - 2032 (USD Million)
  • TABLE 151 Latin America travel vaccines market size, by application, 2018 - 2022 (USD Million)
  • TABLE 152 Latin America travel vaccines market size, by application, 2023 - 2032 (USD Million)
  • TABLE 153 Brazil travel vaccines market size, by composition, 2018 - 2022 (USD Million)
  • TABLE 154 Brazil travel vaccines market size, by composition, 2023 - 2032 (USD Million)
  • TABLE 155 Brazil travel vaccines market size, by disease type, 2018 - 2022 (USD Million)
  • TABLE 156 Brazil travel vaccines market size, by disease type, 2023 - 2032 (USD Million)
  • TABLE 157 Brazil travel vaccines market size, by application, 2018 - 2022 (USD Million)
  • TABLE 158 Brazil travel vaccines market size, by application, 2023 - 2032 (USD Million)
  • TABLE 159 Mexico travel vaccines market size, by composition, 2018 - 2022 (USD Million)
  • TABLE 160 Mexico travel vaccines market size, by composition, 2023 - 2032 (USD Million)
  • TABLE 161 Mexico travel vaccines market size, by disease type, 2018 - 2022 (USD Million)
  • TABLE 162 Mexico travel vaccines market size, by disease type, 2023 - 2032 (USD Million)
  • TABLE 163 Mexico travel vaccines market size, by application, 2018 - 2022 (USD Million)
  • TABLE 164 Mexico travel vaccines market size, by application, 2023 - 2032 (USD Million)
  • TABLE 165 Rest of Latin America travel vaccines market size, by composition, 2018 - 2022 (USD Million)
  • TABLE 166 Rest of Latin America travel vaccines market size, by composition, 2023 - 2032 (USD Million)
  • TABLE 167 Rest of Latin America travel vaccines market size, by disease type, 2018 - 2022 (USD Million)
  • TABLE 168 Rest of Latin America travel vaccines market size, by disease type, 2023 - 2032 (USD Million)
  • TABLE 169 Rest of Latin America travel vaccines market size, by application, 2018 - 2022 (USD Million)
  • TABLE 170 Rest of Latin America travel vaccines market size, by application, 2023 - 2032 (USD Million)
  • TABLE 171 Middle East & Africa travel vaccines market size, by country, 2018 - 2022 (USD Million)
  • TABLE 172 Middle East & Africa travel vaccines market size, by country, 2023 - 2032 (USD Million)
  • TABLE 173 Middle East & Africa travel vaccines market size, by composition, 2018 - 2022 (USD Million)
  • TABLE 174 Middle East & Africa travel vaccines market size, by composition, 2023 - 2032 (USD Million)
  • TABLE 175 Middle East & Africa travel vaccines market size, by disease type, 2018 - 2022 (USD Million)
  • TABLE 176 Middle East & Africa travel vaccines market size, by disease type, 2023 - 2032 (USD Million)
  • TABLE 177 Middle East & Africa travel vaccines market size, by application, 2018 - 2022 (USD Million)
  • TABLE 178 Middle East & Africa travel vaccines market size, by application, 2023 - 2032 (USD Million)
  • TABLE 179 South Africa travel vaccines market size, by composition, 2018 - 2022 (USD Million)
  • TABLE 180 South Africa travel vaccines market size, by composition, 2023 - 2032 (USD Million)
  • TABLE 181 South Africa travel vaccines market size, by disease type, 2018 - 2022 (USD Million)
  • TABLE 182 South Africa travel vaccines market size, by disease type, 2023 - 2032 (USD Million)
  • TABLE 183 South Africa travel vaccines market size, by application, 2018 - 2022 (USD Million)
  • TABLE 184 South Africa travel vaccines market size, by application, 2023 - 2032 (USD Million)
  • TABLE 185 Saudi Arabia travel vaccines market size, by composition, 2018 - 2022 (USD Million)
  • TABLE 186 Saudi Arabia travel vaccines market size, by composition, 2023 - 2032 (USD Million)
  • TABLE 187 Saudi Arabia travel vaccines market size, by disease type, 2018 - 2022 (USD Million)
  • TABLE 188 Saudi Arabia travel vaccines market size, by disease type, 2023 - 2032 (USD Million)
  • TABLE 189 Saudi Arabia travel vaccines market size, by application, 2018 - 2022 (USD Million)
  • TABLE 190 Saudi Arabia travel vaccines market size, by application, 2023 - 2032 (USD Million)
  • TABLE 191 Rest of Middle East & Africa travel vaccines market size, by composition, 2018 - 2022 (USD Million)
  • TABLE 192 Rest of Middle East & Africa travel vaccines market size, by composition, 2023 - 2032 (USD Million)
  • TABLE 193 Rest of Middle East & Africa travel vaccines market size, by disease type, 2018 - 2022 (USD Million)
  • TABLE 194 Rest of Middle East & Africa travel vaccines market size, by disease type, 2023 - 2032 (USD Million)
  • TABLE 195 Rest of Middle East & Africa travel vaccines market size, by application, 2018 - 2022 (USD Million)
  • TABLE 196 Rest of Middle East & Africa travel vaccines market size, by application, 2023 - 2032 (USD Million)

Charts & Figures

  • FIG 1 GMI report coverage: Critical research elements
  • FIG 2 Top-down approach
  • FIG 3 Market estimation and forecast methodology
  • FIG 4 Market forecasting methodology
  • FIG 5 Breakdown of primary participants
  • FIG 6 Travel vaccines industry 360 degree synopsis, 2018 - 2032
  • FIG 7 Growth potential analysis, by composition
  • FIG 8 Growth potential analysis, by disease type
  • FIG 9 Growth potential analysis, by application
  • FIG 10 Porter's analysis
  • FIG 11 PESTEL analysis
  • FIG 12 Company matrix analysis, 2022
  • FIG 13 Global company market share analysis, 2022
  • FIG 14 Competitive positioning matrix, 2022
  • FIG 15 Strategic dashboard, 2022